The FDA approves Samsung’s sleep apnea function for the Galaxy Watch.
Later this year, the tool will be released by the corporation.
Samsung has announced that a sleep apnea detection function on Galaxy Watch devices in the US has received approval from the Food and Drug Administration. The business points out that this is the first permission of its sort in the US; before, South Korean authorities had given the feature the go-ahead for usage in that nation.
In the second half of this year, Samsung intends to integrate the sleep apnea monitoring feature with Galaxy Watch wearables that are suitable. Through the Samsung Health Check app, it will be accessible.
Through the use of their phone and wristwatches, those 22 years of age and older who have not yet received a sleep apnea diagnosis may now look for symptoms of the illness. During two nights of monitoring, it searches for indications of moderate to severe obstruction of respiration (OSA). To access the function, users must record more than four hours of sleep twice over ten days.
According to the National Sleep Foundation, OSA is a prevalent, chronic disorder that affects around 25% of men and 10% of women in the US. People who have the illness often cease breathing during their sleep, which can impair oxygen delivery, lower sleep quality, and increase fatigue during the day. Untreated, “sleep apnea may raise the risk of developing cardiovascular illnesses such as hypertension, heart failure, coronary artery disease, irregular heartbeats and stroke,” according to Samsung. The tool should assist more individuals in identifying moderate and severe types of the ailment and in seeking medical attention when necessary, according to the business.
Additional devices have picked up additional variations of the functionality, which is part of Samsung’s ongoing efforts to support its customers’ quality sleep. Withings upgraded their sleep monitoring mat in 2020 with a sleep apnea diagnosis capability.
